OPTN
OptiNose (OPTN)
$70
About OptiNose (OPTN)
OptiNose, Inc. operates as a pharmaceutical company. The firm engages in the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists. Its products include the XHANCE and ONZETRA Xsail. The company was founded by Per Gisle Djupesland and Helena Kyttari Djupesland in October 2000 and is headquartered in Yardley, PA.
Details
Daily high
$0.73
Daily low
$0.70
Price at open
$0.70
52 Week High
$2.10
52 Week Low
$0.65
Market cap
106.0M
Dividend yield
0.00%
Volume
54,751
Avg. volume
510,998
P/E ratio
-1.91
OptiNose News
Details
Daily high
$0.73
Daily low
$0.70
Price at open
$0.70
52 Week High
$2.10
52 Week Low
$0.65
Market cap
106.0M
Dividend yield
0.00%
Volume
54,751
Avg. volume
510,998
P/E ratio
-1.91